Also at relapse, AML bulk cells in most patients were positive for CD33 (98.1%), CD123 (98.1%), CLL1 (71.4%), TIM3 (80.0%) and CD244 (97.1%). The gene discussed is HAVCR2; the disease is acute myeloid leukemia.